In:
Biotechnology Progress, Wiley, Vol. 33, No. 3 ( 2017-05), p. 726-736
Abstract:
For efficient biofarming we attempted to enrich plant interstitial fluid (IF)/apoplastic fluid with targeted recombinant therapeutic protein. We employed a synthetic human Glucocerebrosidase (GCB), a model biopharmaceutical protein gene in this study. Results Twenty one Nicotiana varieties, species and hybrids were initially screened for individual IF recovery and based on the findings, we selected Nicotiana tabacum NN (S‐9‐6), Nicotiana tabacum nn (S‐9‐7) and Nicotiana benthamiana (S‐6‐6) as model plants for raising transgenic expressing GCB via Agrobacterium mediated transformation under the control of M24 promoter; GCB specific activity in each transgenic lines were analyzed and we observed higher concentration of recombinant GCB in IF of these transgenic lines (S‐9‐6, S‐9‐7, and S‐6‐6) in comparison to their concentration in crude leaf extracts. Conclusion Recovery of valuable therapeutics in plant IF as shown in the present study holds great promise for promoting plant based biofarming. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:726–736, 2017
Type of Medium:
Online Resource
ISSN:
8756-7938
,
1520-6033
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
2003526-3
SSG:
12
Bookmarklink